American Journal of Cardiology
Volume 104, Issue 3 , Pages 338-342 , 1 August 2009

Antiplatelet Therapy in Patients With Anticoagulants Undergoing Percutaneous Coronary Stenting (from STENTIng and oral antiCOagulants [STENTICO])

  • Martine Gilard, MD

      Affiliations

    • Department of Cardiology, University Hospital of Brest, Brest, France
    • Corresponding Author InformationCorresponding author: Tel: (+33) 2-9834-7505; fax: (+33) 2-9805-3277
    • ,
  • Didier Blanchard, MD

      Affiliations

    • Department of Cardiology, Clinique St. Gatien, Tours, France
    • ,
  • Gérard Helft, MD

      Affiliations

    • Department of Cardiology, University Hospital of Paris, Paris, France
    • ,
  • Didier Carrier, MD

      Affiliations

    • Department of Cardiology, University Hospital of Toulouse, Toulouse, France
    • ,
  • Helene Eltchaninoff, MD

      Affiliations

    • Department of Cardiology, University Hospital of Rouen, Rouen, France
    • ,
  • Loic Belle, MD

      Affiliations

    • Department of Cardiology, Hospital of Annecy, Annecy, France
    • ,
  • Gérard Finet, MD

      Affiliations

    • University Hospital of Lyon, Lyon, France
    • ,
  • Hervé Le Breton, MD

      Affiliations

    • Department of Cardiology, University Hospital of Rennes, Rennes, France
    • ,
  • Jacques Boschat, MD

      Affiliations

    • Department of Cardiology, University Hospital of Brest, Brest, France
    • ,
  • STENTICO Investigators

Received 2 January 2009 ,Revised 14 March 2009 ,Accepted 14 March 2009.

References 

  1. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med. 1998;339:1665–1671
  2. Bertrand ME, Legrand V, Boland J, Fleck E, Bonnier J, Emmanuelson H, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: the Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) study. Circulation. 1998;98:1597–1603
  3. Taniuchi M, Kurz HI, Lasala JM. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. Circulation. 2001;104:539–543
  4. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113:156–175
  5. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804–847
  6. Schömig A, Neumann FJ, Kastrati A, Schühlen H, Blasini R, Hadamitzky M, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med. 1996;334:1084–1089
  7. Gage BF, Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation. 2004;110:2287–2292
  8. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673–682
  9. Rubboli A, Colletta M, Herzfeld J, Sangiorgio P, Di Pasquale G. Peri-procedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention. Coron Artery Dis. 2007;18:193–199
  10. Porter A, Konstantino Y, Iakobishvili Z, Shachar L, Battler A, Hasdai D. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006;68:56–61
  11. Lip GYH, Karpha M. Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline. Chest. 2006;130:1823–1827
  12. Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, et al. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J. 2004;147:463–467
  13. Mattichak SJ, Reed PS, Gallagher MJ, Boura JA, O'Neill WW, Kahn JK. Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction. J Interv Cardiol. 2005;18:163–166
  14. Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, et al. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol. 2006;18:162–164
  15. Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, et al. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?. Eur Heart J. 2007;28:1717–1722
  16. Rubboli A, Colletta M, Sangiorgio P, Di Pasquale G. Antithrombotic treatment after coronary artery stenting in patients on chronic oral anticoagulation: an international survey of current clinical practice. Ital Heart J. 2004;5:851–856
  17. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, Rigattieri S, Turri M, Anselmi M, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol. 2004;44:349–356
  18. Madan P, Elayda MA, Lee VV, Wilson JM. Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score. Am Heart J. 2008;155:1068–1074
  19. Segal AZ, Abernethy WB, Palacios IF, BeLue R, Rordorf G. Stroke as a complication of cardiac catheterization: risk factors and clinical features. Neurology. 2001;56:975–977
  20. Fuchs S, Stabile E, Kinnaird TD, Mintz GS, Gruberg L, Canos DA, et al. Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications. Circulation. 2002;106:86–91
  21. Leker RR, Pollak A, Abramsky O, Ben-Hur T. Abundance of left hemispheric embolic strokes complicating coronary angioplasty and PTCA. J Neurol Neurosurg Psychiatry. 1999;66:116–117
  22. Dukkipati S, O'Neill WW, Harjai KJ, Sanders WP, Deo D, Boura JA, et al. Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J Am Coll Cardiol. 2004;43:1161–1167

PII: S0002-9149(09)00815-7

doi: 10.1016/j.amjcard.2009.03.053

American Journal of Cardiology
Volume 104, Issue 3 , Pages 338-342 , 1 August 2009

Article Tools